Mabpharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	94.16	89.34	173.35	33.57	81.56	484.85
Trading Asset Securities	-	-	-	15.04	-	-
Cash & Short-Term Investments	94.16	89.34	173.35	48.61	81.56	484.85
Cash Growth	27.13%	-48.46%	256.59%	-40.39%	-83.18%	-36.86%
Accounts Receivable	145.34	94.53	19.42	9.53	0.79	-
Other Receivables	3.14	9.2	23.97	30.66	41.47	16.31
Receivables	148.48	103.73	43.39	40.2	42.27	16.31
Inventory	145.78	111.01	102.04	100.8	53.21	33.43
Restricted Cash	-	39.34	-	-	-	-
Other Current Assets	21.88	22.35	23.43	11.52	70.74	34.54
Total Current Assets	410.3	365.77	342.21	201.12	247.77	569.13
Property, Plant & Equipment	592.47	614.25	686.54	704.01	561.05	512.62
Long-Term Deferred Charges	61.7	33.35	-	-	-	-
Other Long-Term Assets	3.38	2.85	6.23	12.39	91.09	81.29
Total Assets	1,068	1,016	1,035	917.52	899.9	1,163
Accounts Payable	29.24	11.71	10.03	16.77	60.09	4.52
Accrued Expenses	34.62	36.1	47.25	54.73	57.9	36.52
Short-Term Debt	-	-	-	-	0.74	0.02
Current Portion of Long-Term Debt	89.99	80.05	108.26	-	-	-
Current Portion of Leases	20.16	17.21	17	13.29	9.28	8.53
Current Income Taxes Payable	8.46	0.63	0.66	0.94	1.2	0.59
Current Unearned Revenue	56.12	45.5	40.28	26.6	37.93	80.72
Other Current Liabilities	144.43	120.93	92.72	76.07	67.87	71.72
Total Current Liabilities	383.01	312.13	316.19	188.4	235	202.63
Long-Term Debt	166.46	184.04	123.97	129.71	-	-
Long-Term Leases	28.41	30.29	33.35	28.34	36.41	31.82
Long-Term Unearned Revenue	343.83	351.95	308.03	122.43	26.51	47.11
Other Long-Term Liabilities	47.28	48.88	48.38	47.7	-	-
Total Liabilities	968.98	927.28	829.92	516.58	297.92	281.55
Common Stock	2.8	2.8	2.8	2.8	2.8	2.8
Additional Paid-In Capital	1,401	1,401	1,401	1,401	1,401	1,401
Retained Earnings	-1,358	-1,361	-1,233	-1,023	-812.5	-520.76
Comprehensive Income & Other	53.28	46.25	34.42	20.95	11.17	-1.07
Total Common Equity	98.86	88.93	205.06	400.94	601.98	881.49
Shareholders' Equity	98.86	88.93	205.06	400.94	601.98	881.49
Total Liabilities & Equity	1,068	1,016	1,035	917.52	899.9	1,163
Total Debt	305.01	311.59	282.57	171.34	46.43	40.37
Net Cash (Debt)	-210.85	-222.25	-109.23	-122.73	35.13	444.48
Net Cash Growth	-	-	-	-	-92.10%	-32.64%
Net Cash Per Share	-0.05	-0.05	-0.03	-0.03	0.01	0.11
Filing Date Shares Outstanding	4,124	4,124	4,124	4,124	4,124	4,124
Total Common Shares Outstanding	4,124	4,124	4,124	4,124	4,124	4,124
Working Capital	27.29	53.65	26.02	12.72	12.77	366.5
Book Value Per Share	0.02	0.02	0.05	0.10	0.15	0.21
Tangible Book Value	98.86	88.93	205.06	400.94	601.98	881.49
Tangible Book Value Per Share	0.02	0.02	0.05	0.10	0.15	0.21
Buildings	-	198.29	198.21	117.92	117.92	-
Machinery	-	389.32	357.53	335.14	280.95	150.45
Construction In Progress	-	125.3	167.23	239.12	98.4	310.72
Leasehold Improvements	-	79.09	78.79	78.79	78.63	34.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.